| DIRECT COMPETITOR COMPARISON | |
| RDEA | AMGN | LLY | Pvt1 | Industry | | Market Cap: | 251.64M | 57.02B | 42.07B | N/A | 161.24M | | Employees: | 81 | 16,700 | 40,500 | 11,1741 | 103 | | Qtrly Rev Growth (yoy): | N/A | -1.60% | 6.80% | N/A | 20.50% | | Revenue (ttm): | 14.73M | 14.58B | 21.11B | 13.42B1 | 46.74M | | Gross Margin (ttm): | 100.00% | 84.99% | 82.33% | N/A | 68.58% | | EBITDA (ttm): | -35.87M | 6.71B | 7.74B | N/A | -7.12M | | Oper Margins (ttm): | -248.05% | 38.71% | 30.97% | N/A | 2.25% | | Net Income (ttm): | -37.20M | 4.74B | -216.00M | N/A | N/A | | EPS (ttm): | -2.137 | 4.585 | -0.197 | N/A | -0.17 | | P/E (ttm): | N/A | 12.29 | N/A | N/A | 17.12 | | PEG (5 yr expected): | N/A | 1.31 | 4 | N/A | 1.04 | | P/S (ttm): | 18.03 | 3.92 | 2.01 | N/A | 4.17 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.34 | -0.28% | 57.02B | 12.29 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.06 | 0.30% | 13.61B | 15.75 | | Genzyme Corp. | GENZ | 50.72 | -0.69% | 13.46B | 28.92 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.03 | -1.14% | 41.42B | 17.80 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.52 | -0.86% | 8.83B | 1010.61 | | Teva Pharmaceutical Industries Limited | TEVA | 52.53 | -0.66% | 46.28B | 48.06 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.21 | 0.68% | 3.95B | 19.18 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.82 | -1.09% | 2.93B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.83 | -1.00% | 5.45B | 109.39 | | Pfizer Inc. | PFE | 18.24 | -0.05% | 147.19B | 15.15 | | Johnson & Johnson | JNJ | 62.75 | -0.22% | 173.13B | 13.70 | | GlaxoSmithKline plc | GSK | 41.29 | -2.30% | 104.67B | 13.11 | | Sanofi-Aventis | SNY | 37.84 | -1.54% | 98.80B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.42 | 0.07% | 125.87B | 16.59 | | RHHBY.PK | 40.80 | -1.59% | N/A | N/A | | AstraZeneca plc | AZN | 44.63 | -1.46% | 64.71B | 8.96 | | Abbott Laboratories | ABT | 54.24 | 0.30% | 83.90B | 14.70 | | Bristol-Myers Squibb Co. | BMY | 25.36 | -0.08% | 50.24B | 13.12 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|